We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BJ icon
1151
BJs Wholesale Club
BJ
$12.3B
– –
-2,487
Closed -$268K
BKR icon
1152
Baker Hughes
BKR
$63.6B
– –
-11,116
Closed -$426K
BLFS icon
1153
BioLife Solutions
BLFS
$1.69B
– –
-12,146
Closed -$262K
BORR
1154
Borr Drilling
BORR
$1.28B
– –
-53,543
Closed -$98K
BP icon
1155
BP
BP
$110B
– –
-36,737
Closed -$1.1M
BPMC
1156
DELISTED
Blueprint Medicines
BPMC
– –
-60,154
Closed -$7.71M
BRBR icon
1157
BellRing Brands
BRBR
$1.32B
– –
-12,238
Closed -$709K
BRDG
1158
DELISTED
Bridge Investment Group
BRDG
– –
-320,101
Closed -$3.2M
BRK.B icon
1159
Berkshire Hathaway Class B
BRK.B
$1.14T
– –
-1,314
Closed -$638K
BTBT icon
1160
Bit Digital
BTBT
$454M
– –
-195,850
Closed -$429K
BTU icon
1161
Peabody Energy
BTU
$3B
– –
-31,485
Closed -$423K
CAR icon
1162
Avis
CAR
$4.9B
– –
-4,635
Closed -$784K
CAVA icon
1163
CAVA Group
CAVA
$7.17B
– –
-2,619
Closed -$221K
CB icon
1164
Chubb
CB
$134B
– –
-756
Closed -$219K
CBSH icon
1165
Commerce Bancshares
CBSH
$8.44B
– –
-3,721
Closed -$220K
CCK icon
1166
Crown Holdings
CCK
$13.1B
– –
-5,330
Closed -$549K
CCOI icon
1167
Cogent Communications
CCOI
$528M
– –
-31,659
Closed -$1.53M
CDNA icon
1168
CareDx
CDNA
$2.44B
– –
-20,000
Closed -$391K
CDRE icon
1169
Cadre Holdings
CDRE
$1.4B
– –
-7,384
Closed -$235K
CE icon
1170
Celanese
CE
$4.88B
– –
-10,000
Closed -$553K
CF icon
1171
CF Industries
CF
$18.4B
– –
-8,008
Closed -$737K
CHX
1172
DELISTED
ChampionX
CHX
– –
-115,686
Closed -$2.87M
CLBT icon
1173
Cellebrite
CLBT
$3.97B
– –
-12,829
Closed -$205K
CLDX icon
1174
Celldex Therapeutics
CLDX
$3.37B
– –
-31,066
Closed -$632K
CME icon
1175
CME Group
CME
$94.8B
– –
-1,277
Closed -$352K
45 46
47
48 49

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.